Amphibian embryos as an alternative model to study the pharmaceutical toxicity of cyclophosphamide and ibuprofen

Author:

Turani Blerta,Aliko Valbona,Faggio Caterina

Abstract

Pharmaceuticals are becoming potentially ubiquitous pollutants because of their extensive use by man. One of the most frequent groups of pharmaceuticals that have been identified as particularly concerning is that of nonsteroidal anti-inflammatory and chemotherapeutic drugs. In Albania, studies to determine the risk of pharmaceuticals in conjunction with their occurrence in water bodies and their adverse effects on living organisms, including humans, are scarce. The purpose of this study was to elucidate the possible toxic effects of ibuprofen (IBU) and cyclophosphamide (CP) on cellular physiology of frog tadpoles. For this purpose, individuals of Pelophylax shqipericus belonging to stage 21 Gosner were exposed to sub-lethal concentration (5 μg/L) of IBU and CP for 48 hours, and erythrocyte abnormalities and micronucleated cell frequency were evaluated as endpoints. Blood smears from tadpoles exposed to CP for 48 hours showed a pronounced decrease in the number of red blood cells and an increase in the percentage of micronucleated erythrocytes through chromatin fragmentation, while abnormalities like cellular and nuclear vacuolization, collapse and rupture of the cell membrane were caused by IBU toxicity. Understanding the biological effects of these drugs on frog tadpoles can help in using these animals as reliable bio-indicator organisms in monitoring aquatic environments health.

Publisher

PAGEPress Publications

Subject

Biochemistry (medical),Plant Science,General Biochemistry, Genetics and Molecular Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3